NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD
Scinai Immunotherapeutics Ltd. (SCNI) has a market capitalization of $802.37K and trades at $0.61. The 52-week range is 0.55-6.18.
Key metrics include annual revenue of $658K.
The stock has a beta of 1.89, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
